Xiidra

Warnings and Precautions for Xiidra

Xiidra does not carry a formal FDA boxed warning. However, patients and prescribers should be aware of the following important safety information.

Contact Lens Use

Xiidra should not be administered while wearing contact lenses. Lenses should be removed prior to instillation and may be reinserted 15 minutes after administration.

Hypersensitivity

Xiidra is contraindicated in patients with known hypersensitivity to lifitegrast or any other ingredient in the formulation.

Common Adverse Reactions

The most commonly reported adverse reactions, occurring in 5% to 25% of patients, include instillation-site irritation, altered taste sensation (dysgeusia), and reduced visual acuity.

How to Access Xiidra in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation and Availability of Xiidra

Xiidra is manufactured and marketed by Bausch + Lomb. It is sourced through authorized distribution channels for patients seeking named-patient import into India.

Required Documentation

Patients typically need a valid prescription from a treating ophthalmologist confirming dry eye disease diagnosis. NPP's regulatory team assists in preparing and verifying the documentation needed for a compliant import.

Availability

As an FDA-approved therapy for dry eye disease, Xiidra is sourced through authorized channels and imported under GDP-compliant logistics to preserve product quality throughout transit.

Sourcing and Delivery of Xiidra

NPP sources Xiidra directly from authorized pharmaceutical distributors to ensure product authenticity and full traceability. Every shipment is handled under Good Distribution Practice (GDP) conditions from origin to the patient's doorstep.

Storage and Handling

Xiidra should be stored at 20°C to 25°C, with excursions permitted between 15°C and 30°C, and this condition is maintained throughout transit.

Delivery Timelines

Once documentation and regulatory approvals are in place, delivery timelines are communicated transparently at the time of quotation, accounting for import clearance and last-mile logistics to the patient's city.

Availability of Xiidra Across Major Cities in India

Patients across India can access Xiidra through NPP's regulated import pathway, with ophthalmology specialists in major cities supporting the treatment process.

Mumbai

Leading hospitals in Mumbai support ophthalmology care coordination and documentation for Xiidra access.

Delhi

Delhi's major hospitals assist patients with prescription support and documentation for Xiidra.

Bangalore

Bangalore's specialist network offers access coordination for eligible dry eye patients seeking Xiidra.

Chennai

Chennai-based ophthalmology specialists coordinate Xiidra access alongside comprehensive dry eye care.

Hyderabad

Hyderabad's care institutions support patients pursuing Xiidra therapy.

Kolkata

Kolkata's specialist centers help coordinate documentation and treatment access for Xiidra.

Pune

Pune-based specialists assist with prescription support and Xiidra treatment planning.

Ahmedabad

Ahmedabad's specialty hospitals support the import and treatment process for Xiidra.

Kochi

Kochi's specialist units assist patients with the documentation needed for Xiidra access.

Chandigarh

Chandigarh's care centers support Xiidra treatment coordination for patients from North India.

Jaipur

Jaipur's specialists help patients navigate the Xiidra access process.

Lucknow

Lucknow-based centers assist patients pursuing Xiidra therapy.

Bhubaneswar

Bhubaneswar's institutions support access to Xiidra for eligible patients.

Guwahati

Guwahati's specialists help coordinate Xiidra access for patients across the Northeast.

Patients in other cities across India can also access Xiidra through NPP's nationwide coordination network.